The readers of MedTech Intelligence continue to crave any content that will help them learn more about the Medical Device Regulation.
How manufacturers can better understand their customers in a rapidly changing provider environment.
Look for the good, the bad, and the ugly, but above all, look for anything that affects patient safety.
Industry revenue was only up 4%, according to Ernst & Young’s annual Pulse of the Industry report.
The market is projected to hit nearly $4.2 billion by 2025.
The Wall Street Journal reports that the scandal-ridden company will dissolve after failing to sell itself, and investors will lose nearly $1 billion.
Following protocols and maintaining compliance have been common themes.
MRI-compatible pacemakers are among the technologies gaining traction.
Research and development activities to find potential treatments using next generation sequencing for various fatal conditions including melanoma, epilepsy, antibody deficiency, and other diseases have gained traction. In April, FDA finalized two guidance documents to speed up development of NGS-based tests.
The increase is significantly less than FY 2018, which saw user fees go up 33%.